• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.

作者信息

Macdougall Iain C, Vernon Katherine

机构信息

Department of Renal Medicine, King's College Hospital, London, UK.

出版信息

Am J Nephrol. 2017;45(1):60-62. doi: 10.1159/000451069. Epub 2016 Nov 29.

DOI:10.1159/000451069
PMID:27894115
Abstract
摘要

相似文献

1
Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.补体激活相关的假性过敏：对静脉注射铁剂过敏反应的新认识。
Am J Nephrol. 2017;45(1):60-62. doi: 10.1159/000451069. Epub 2016 Nov 29.
2
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.静脉注射铁剂的超敏反应：风险最小化与管理指南
Haematologica. 2014 Nov;99(11):1671-6. doi: 10.3324/haematol.2014.111492.
3
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.不同静脉铁制剂的体外补体激活作用各异。
Am J Nephrol. 2017;45(1):49-59. doi: 10.1159/000451060. Epub 2016 Nov 26.
4
Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?纳米颗粒诱导猪过敏的机制：补体参与还是不参与？
Drug Discov Today. 2018 Mar;23(3):487-492. doi: 10.1016/j.drudis.2018.01.025. Epub 2018 Jan 8.
5
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.补体激活作为一个与仿制药脂质体及其他纳米颗粒药物研发相关的生物等效性问题。
Biochem Biophys Res Commun. 2015 Dec 18;468(3):490-7. doi: 10.1016/j.bbrc.2015.06.177. Epub 2015 Jul 14.
6
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.由脂质体、静脉注射药物的胶束载体和放射性造影剂引起的补体激活相关假过敏反应。
Crit Rev Ther Drug Carrier Syst. 2001;18(6):567-606.
7
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.非免疫原性葡聚糖包被的超顺磁性氧化铁纳米颗粒：一种用于磁共振成像的生物相容性、尺寸可调的造影剂。
Int J Nanomedicine. 2017 Jul 24;12:5223-5238. doi: 10.2147/IJN.S138108. eCollection 2017.
8
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.一种用于药物载体纳米系统和其他药物的补体介导输注反应的猪模型。
Adv Drug Deliv Rev. 2012 Dec;64(15):1706-16. doi: 10.1016/j.addr.2012.07.005. Epub 2012 Jul 20.
9
Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation.铁纳米药物会诱导 Toll 样受体激活、细胞因子产生和补体激活。
Biomaterials. 2017 Mar;119:68-77. doi: 10.1016/j.biomaterials.2016.11.025. Epub 2016 Nov 21.
10
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.补体介导的对脂质体和其他基于脂质的纳米颗粒过敏反应的动物模型。
J Liposome Res. 2007;17(2):107-17. doi: 10.1080/08982100701375118.

引用本文的文献

1
Oral and Intravenous Iron Therapy.口服和静脉铁剂治疗。
Adv Exp Med Biol. 2025;1480:371-386. doi: 10.1007/978-3-031-92033-2_24.
2
Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies.解析补体介导的过敏反应的复杂性：治疗策略的新兴进展综述
Arch Dermatol Res. 2025 Feb 19;317(1):439. doi: 10.1007/s00403-025-03971-z.
3
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose.
一项系统性文献回顾和荟萃分析评估了铁低聚糖或羧基麦芽糖铁给药后严重或重度过敏反应的发生率。
Int J Clin Pharm. 2023 Jun;45(3):604-612. doi: 10.1007/s11096-023-01548-2. Epub 2023 Apr 3.
4
Molecular Mechanisms of Scombroid Food Poisoning.鲭鱼中毒的分子机制。
Int J Mol Sci. 2023 Jan 3;24(1):809. doi: 10.3390/ijms24010809.
5
Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination.辉瑞-BioNTech COVID-19 疫苗接种后出现 hilar lymphadenopathy、tubulointerstitial nephritis 和 dense deposit disease。
CEN Case Rep. 2023 Aug;12(3):287-291. doi: 10.1007/s13730-022-00762-7. Epub 2022 Dec 13.
6
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations.纳米材料在健康和疾病中的免疫毒性：鉴定易感人群中免疫调节剂的当前挑战和新兴方法。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Nov;14(6):e1804. doi: 10.1002/wnan.1804.
7
Hypersensitivity to Intravenous Iron Preparations.对静脉注射铁制剂过敏
Children (Basel). 2022 Sep 27;9(10):1473. doi: 10.3390/children9101473.
8
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.高剂量静脉注射铁剂（如羧基麦芽糖铁或去铁胺麦芽糖铁）：获益-风险评估。
Drug Saf. 2022 Oct;45(10):1019-1036. doi: 10.1007/s40264-022-01216-w. Epub 2022 Sep 6.
9
Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions.成人既往输注反应史与无既往输注反应史患者的不良事件与静脉铁剂制剂分析。
JAMA Netw Open. 2022 Mar 1;5(3):e224488. doi: 10.1001/jamanetworkopen.2022.4488.
10
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy.羧基麦芽糖铁用于治疗孕期缺铁和缺铁性贫血。
Ther Adv Hematol. 2021 May 31;12:20406207211018042. doi: 10.1177/20406207211018042. eCollection 2021.